The starting dose is 0.25 milligrams
Although GLP-1 RAs have been on the market for 20 years, its also possible new risks may emerge as more people take GLP-1 RAs over many years
The following data were obtained at baseline as well as three and six months (M3, M6) after initiation of the treatment with a GLP-1-RA + UCWM or UCWM alone: body weight, monthly headache days (MHD) recorded in a headache diary, and ophthalmological assessment including visual acuity, perimetry, fundoscopy, optical coherence tomography (OCT) and ocular ultrasonography
Rev Endocr Metab Disord 24 , 10891101 (2023)
Rubino DM, Greenway FL, Khalid U et al (2022) Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes
Best day of the week for your GLP-1 shot For weekly formulations, the day you choose matters almost as much as the time